Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cesarean Section | 26 | 2020 | 1365 | 3.120 |
Why?
|
Disabled Persons | 9 | 2017 | 1212 | 2.080 |
Why?
|
Pregnancy | 134 | 2023 | 29142 | 2.050 |
Why?
|
Pregnancy Complications | 17 | 2021 | 2862 | 1.840 |
Why?
|
Diabetes, Gestational | 21 | 2021 | 1184 | 1.640 |
Why?
|
Pregnant Women | 5 | 2015 | 568 | 1.460 |
Why?
|
Pregnancy Outcome | 25 | 2021 | 2796 | 1.380 |
Why?
|
Personal Autonomy | 7 | 2021 | 298 | 1.350 |
Why?
|
Prenatal Care | 9 | 2016 | 1092 | 1.350 |
Why?
|
Home Childbirth | 3 | 2015 | 51 | 1.330 |
Why?
|
Mobility Limitation | 5 | 2017 | 410 | 1.330 |
Why?
|
Delivery, Obstetric | 14 | 2020 | 906 | 1.280 |
Why?
|
Labor, Induced | 6 | 2020 | 146 | 1.270 |
Why?
|
Ethics, Medical | 7 | 2017 | 792 | 1.210 |
Why?
|
Pregnancy Complications, Cardiovascular | 9 | 2015 | 501 | 0.980 |
Why?
|
Obstetrics | 7 | 2016 | 658 | 0.950 |
Why?
|
Analgesia, Obstetrical | 2 | 2019 | 177 | 0.930 |
Why?
|
Embolism, Amniotic Fluid | 2 | 2013 | 19 | 0.900 |
Why?
|
Fetal Macrosomia | 5 | 2013 | 124 | 0.790 |
Why?
|
Developed Countries | 2 | 2016 | 437 | 0.780 |
Why?
|
Roseolovirus Infections | 1 | 2021 | 45 | 0.760 |
Why?
|
Herpesvirus 6, Human | 1 | 2021 | 95 | 0.740 |
Why?
|
Ultrasonography, Prenatal | 9 | 2013 | 1695 | 0.740 |
Why?
|
Visitors to Patients | 1 | 2020 | 35 | 0.730 |
Why?
|
Hemorrhagic Fever, Ebola | 2 | 2015 | 428 | 0.700 |
Why?
|
Pre-Eclampsia | 17 | 2018 | 1200 | 0.700 |
Why?
|
Attitude of Health Personnel | 6 | 2014 | 3842 | 0.690 |
Why?
|
Virus Integration | 1 | 2021 | 299 | 0.670 |
Why?
|
Fetal Diseases | 5 | 2015 | 903 | 0.670 |
Why?
|
Parturition | 5 | 2018 | 441 | 0.660 |
Why?
|
Hallucinogens | 1 | 2022 | 183 | 0.660 |
Why?
|
Informed Consent | 3 | 2013 | 995 | 0.630 |
Why?
|
Abortion, Legal | 2 | 2012 | 116 | 0.600 |
Why?
|
Bioethical Issues | 2 | 2009 | 124 | 0.590 |
Why?
|
Fetal Growth Retardation | 1 | 2021 | 570 | 0.590 |
Why?
|
Dystocia | 3 | 2013 | 34 | 0.570 |
Why?
|
Ethics, Clinical | 2 | 2008 | 101 | 0.560 |
Why?
|
Echocardiography, Transesophageal | 2 | 2013 | 1132 | 0.560 |
Why?
|
Risk Management | 1 | 2020 | 571 | 0.560 |
Why?
|
Perinatal Mortality | 2 | 2016 | 105 | 0.550 |
Why?
|
Female | 142 | 2023 | 380197 | 0.550 |
Why?
|
Patient Preference | 2 | 2013 | 887 | 0.540 |
Why?
|
Abortion, Spontaneous | 1 | 2021 | 544 | 0.530 |
Why?
|
Pregnancy Trimester, First | 18 | 2018 | 853 | 0.520 |
Why?
|
Decision Making | 4 | 2021 | 3888 | 0.520 |
Why?
|
Cannabis | 1 | 2022 | 438 | 0.520 |
Why?
|
Opiate Substitution Treatment | 1 | 2019 | 404 | 0.510 |
Why?
|
Refusal to Treat | 1 | 2014 | 45 | 0.500 |
Why?
|
Pregnancy, Multiple | 4 | 2009 | 217 | 0.500 |
Why?
|
Congenital Abnormalities | 4 | 2014 | 707 | 0.500 |
Why?
|
Sex Hormone-Binding Globulin | 5 | 2007 | 548 | 0.500 |
Why?
|
Physicians | 5 | 2017 | 4564 | 0.480 |
Why?
|
Moral Obligations | 1 | 2014 | 96 | 0.470 |
Why?
|
Treatment Refusal | 4 | 2012 | 421 | 0.460 |
Why?
|
Postnatal Care | 1 | 2015 | 236 | 0.460 |
Why?
|
Obstetric Labor Complications | 2 | 2009 | 238 | 0.450 |
Why?
|
Extraction, Obstetrical | 2 | 2010 | 26 | 0.450 |
Why?
|
Stereotyping | 1 | 2015 | 241 | 0.440 |
Why?
|
Civil Rights | 1 | 2014 | 132 | 0.440 |
Why?
|
Altruism | 1 | 2014 | 204 | 0.440 |
Why?
|
Virus Replication | 1 | 2021 | 2534 | 0.440 |
Why?
|
Heart Arrest | 2 | 2013 | 1470 | 0.430 |
Why?
|
Infection Control | 1 | 2020 | 964 | 0.430 |
Why?
|
Gynecological Examination | 1 | 2012 | 33 | 0.430 |
Why?
|
Insulin Resistance | 10 | 2021 | 3863 | 0.430 |
Why?
|
Conflict of Interest | 1 | 2017 | 543 | 0.420 |
Why?
|
Physician-Patient Relations | 7 | 2017 | 3227 | 0.420 |
Why?
|
Mandatory Programs | 1 | 2012 | 87 | 0.410 |
Why?
|
Humans | 150 | 2023 | 744220 | 0.410 |
Why?
|
Researcher-Subject Relations | 1 | 2011 | 16 | 0.400 |
Why?
|
Therapeutic Misconception | 1 | 2011 | 8 | 0.400 |
Why?
|
Patient Care | 1 | 2017 | 640 | 0.400 |
Why?
|
Abortion, Induced | 3 | 2013 | 458 | 0.390 |
Why?
|
Marriage | 1 | 2013 | 339 | 0.390 |
Why?
|
Midwifery | 1 | 2013 | 132 | 0.390 |
Why?
|
Maternal Health Services | 3 | 2017 | 455 | 0.390 |
Why?
|
Facility Regulation and Control | 1 | 2011 | 24 | 0.390 |
Why?
|
Hypertension | 11 | 2015 | 8480 | 0.390 |
Why?
|
Family Relations | 1 | 2013 | 321 | 0.380 |
Why?
|
Pregnancy Trimester, Second | 4 | 2016 | 732 | 0.380 |
Why?
|
Neonatology | 1 | 2012 | 122 | 0.380 |
Why?
|
Analgesia, Epidural | 2 | 2011 | 326 | 0.370 |
Why?
|
Prejudice | 1 | 2015 | 570 | 0.370 |
Why?
|
Brain Death | 1 | 2014 | 348 | 0.370 |
Why?
|
Perineum | 3 | 2004 | 211 | 0.360 |
Why?
|
Heart Diseases | 2 | 2013 | 2790 | 0.350 |
Why?
|
Neonatal Abstinence Syndrome | 2 | 2023 | 109 | 0.350 |
Why?
|
Withholding Treatment | 1 | 2014 | 599 | 0.350 |
Why?
|
Research Subjects | 1 | 2011 | 239 | 0.340 |
Why?
|
Practice Management, Medical | 1 | 2011 | 196 | 0.330 |
Why?
|
Opioid-Related Disorders | 3 | 2023 | 2065 | 0.330 |
Why?
|
Parity | 11 | 2010 | 929 | 0.330 |
Why?
|
Gynecology | 2 | 2012 | 513 | 0.330 |
Why?
|
Adult | 80 | 2021 | 214035 | 0.330 |
Why?
|
Vaccination | 1 | 2021 | 3278 | 0.330 |
Why?
|
Birth Weight | 10 | 2016 | 2069 | 0.320 |
Why?
|
Genetic Privacy | 1 | 2008 | 60 | 0.310 |
Why?
|
Ethical Theory | 1 | 2007 | 34 | 0.310 |
Why?
|
Antihypertensive Agents | 5 | 2015 | 2047 | 0.300 |
Why?
|
Interpersonal Relations | 1 | 2015 | 1424 | 0.300 |
Why?
|
Fetal Membranes, Premature Rupture | 3 | 2014 | 140 | 0.300 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2015 | 2026 | 0.290 |
Why?
|
Episiotomy | 3 | 2011 | 24 | 0.290 |
Why?
|
Tissue Banks | 1 | 2007 | 184 | 0.280 |
Why?
|
Fetus | 2 | 2013 | 1880 | 0.280 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 950 | 0.280 |
Why?
|
Obstetric Labor, Premature | 3 | 2016 | 279 | 0.280 |
Why?
|
Health Services Accessibility | 3 | 2015 | 5138 | 0.270 |
Why?
|
Natural Childbirth | 3 | 2013 | 18 | 0.270 |
Why?
|
Blood Glucose | 12 | 2021 | 6259 | 0.270 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2014 | 2234 | 0.270 |
Why?
|
Glucose Intolerance | 4 | 2021 | 577 | 0.270 |
Why?
|
Cooperative Behavior | 2 | 2012 | 1504 | 0.270 |
Why?
|
Anesthesia | 2 | 2017 | 1548 | 0.260 |
Why?
|
Embryo Transfer | 1 | 2009 | 510 | 0.260 |
Why?
|
Wheelchairs | 2 | 2015 | 77 | 0.260 |
Why?
|
Catgut | 1 | 2004 | 7 | 0.250 |
Why?
|
Health Status | 2 | 2015 | 4034 | 0.250 |
Why?
|
Gestational Age | 15 | 2018 | 3493 | 0.250 |
Why?
|
Risk | 8 | 2015 | 9685 | 0.240 |
Why?
|
Self Report | 1 | 2015 | 3558 | 0.240 |
Why?
|
Patients | 1 | 2011 | 900 | 0.240 |
Why?
|
Metformin | 2 | 2008 | 835 | 0.240 |
Why?
|
Polyglactin 910 | 1 | 2004 | 59 | 0.240 |
Why?
|
Abortion, Therapeutic | 1 | 2004 | 35 | 0.240 |
Why?
|
Mothers | 1 | 2015 | 2165 | 0.240 |
Why?
|
Placenta Accreta | 3 | 2011 | 225 | 0.240 |
Why?
|
Medicine | 1 | 2012 | 946 | 0.240 |
Why?
|
Fetal Death | 4 | 2012 | 447 | 0.240 |
Why?
|
Physician's Role | 1 | 2011 | 942 | 0.240 |
Why?
|
Placenta | 6 | 2023 | 1697 | 0.240 |
Why?
|
Labor Presentation | 2 | 2016 | 53 | 0.240 |
Why?
|
Chorionic Villi | 1 | 2003 | 51 | 0.230 |
Why?
|
Education, Medical, Undergraduate | 1 | 2012 | 1007 | 0.230 |
Why?
|
Hospitalization | 3 | 2015 | 10262 | 0.230 |
Why?
|
Pregnancy, High-Risk | 2 | 2014 | 120 | 0.220 |
Why?
|
United States | 22 | 2017 | 69867 | 0.220 |
Why?
|
Pediatrics | 4 | 2013 | 3469 | 0.220 |
Why?
|
Infant, Newborn | 31 | 2023 | 25618 | 0.220 |
Why?
|
Endocrinology | 1 | 2009 | 443 | 0.220 |
Why?
|
Posture | 2 | 2019 | 958 | 0.220 |
Why?
|
Vaginal Birth after Cesarean | 2 | 2015 | 62 | 0.220 |
Why?
|
Birth Injuries | 2 | 2011 | 148 | 0.220 |
Why?
|
Brachial Plexus | 2 | 2011 | 165 | 0.220 |
Why?
|
Abortion, Eugenic | 2 | 2012 | 41 | 0.220 |
Why?
|
Interviews as Topic | 4 | 2017 | 2539 | 0.210 |
Why?
|
Risk Assessment | 14 | 2020 | 23337 | 0.210 |
Why?
|
Postoperative Complications | 4 | 2019 | 15294 | 0.210 |
Why?
|
Private Sector | 1 | 2005 | 392 | 0.210 |
Why?
|
Sutures | 1 | 2004 | 299 | 0.210 |
Why?
|
Postpartum Period | 4 | 2014 | 1086 | 0.210 |
Why?
|
Gastroschisis | 2 | 2013 | 97 | 0.210 |
Why?
|
Patient Transfer | 1 | 2009 | 761 | 0.200 |
Why?
|
Terminal Care | 1 | 2014 | 1694 | 0.200 |
Why?
|
Pregnancy Trimester, Third | 4 | 2018 | 571 | 0.200 |
Why?
|
Calcium Channel Blockers | 2 | 2015 | 690 | 0.190 |
Why?
|
Hormone Replacement Therapy | 1 | 2007 | 744 | 0.190 |
Why?
|
Pain, Postoperative | 2 | 2017 | 1640 | 0.190 |
Why?
|
Mental Health | 1 | 2015 | 3019 | 0.190 |
Why?
|
Quality of Health Care | 1 | 2016 | 4371 | 0.190 |
Why?
|
Hypoglycemia | 1 | 2008 | 861 | 0.190 |
Why?
|
Depression | 2 | 2015 | 7767 | 0.190 |
Why?
|
Placenta Previa | 2 | 2012 | 117 | 0.190 |
Why?
|
Sick Leave | 1 | 2021 | 110 | 0.190 |
Why?
|
Dandy-Walker Syndrome | 1 | 2000 | 43 | 0.180 |
Why?
|
Mass Screening | 4 | 2019 | 5252 | 0.180 |
Why?
|
Stress, Psychological | 1 | 2015 | 4245 | 0.180 |
Why?
|
C-Reactive Protein | 4 | 2007 | 3778 | 0.180 |
Why?
|
Maternal Age | 3 | 2005 | 802 | 0.180 |
Why?
|
Biological Specimen Banks | 1 | 2005 | 712 | 0.180 |
Why?
|
Embryonic Stem Cells | 1 | 2007 | 1294 | 0.180 |
Why?
|
Quality Assurance, Health Care | 1 | 2010 | 2211 | 0.180 |
Why?
|
Risk Factors | 33 | 2018 | 72280 | 0.180 |
Why?
|
Postpartum Hemorrhage | 2 | 2013 | 258 | 0.180 |
Why?
|
Labor, Obstetric | 4 | 2017 | 333 | 0.180 |
Why?
|
Insulin | 4 | 2016 | 6583 | 0.170 |
Why?
|
Tissue and Organ Procurement | 1 | 2007 | 897 | 0.170 |
Why?
|
Counseling | 4 | 2016 | 1523 | 0.170 |
Why?
|
Hypoglycemic Agents | 2 | 2008 | 2875 | 0.170 |
Why?
|
Abruptio Placentae | 1 | 2020 | 118 | 0.170 |
Why?
|
Acid-Base Equilibrium | 1 | 1999 | 185 | 0.170 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2020 | 131 | 0.170 |
Why?
|
Prenatal Diagnosis | 4 | 2012 | 1236 | 0.170 |
Why?
|
Clinical Trials as Topic | 2 | 2013 | 7908 | 0.160 |
Why?
|
Fetal Blood | 1 | 2005 | 1317 | 0.160 |
Why?
|
Genetic Testing | 2 | 2010 | 3443 | 0.160 |
Why?
|
Weight Gain | 1 | 2009 | 2292 | 0.160 |
Why?
|
Prevalence | 8 | 2021 | 15226 | 0.160 |
Why?
|
Triplets | 1 | 1998 | 43 | 0.160 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2020 | 183 | 0.160 |
Why?
|
Chorion | 1 | 1998 | 117 | 0.160 |
Why?
|
Hypertension, Pregnancy-Induced | 3 | 2013 | 489 | 0.160 |
Why?
|
Lobbying | 1 | 2017 | 32 | 0.150 |
Why?
|
Antithyroid Agents | 1 | 1997 | 70 | 0.150 |
Why?
|
Breast Feeding | 2 | 2019 | 1339 | 0.150 |
Why?
|
Socioeconomic Factors | 3 | 2015 | 7784 | 0.150 |
Why?
|
Cervix Uteri | 1 | 2021 | 590 | 0.150 |
Why?
|
Societies | 1 | 2017 | 104 | 0.150 |
Why?
|
Birthing Centers | 2 | 2009 | 7 | 0.140 |
Why?
|
Reference Values | 4 | 2011 | 4982 | 0.140 |
Why?
|
Fetal Viability | 1 | 2016 | 31 | 0.140 |
Why?
|
Substance Abuse Detection | 1 | 2019 | 283 | 0.140 |
Why?
|
Pregnancy Proteins | 4 | 2005 | 229 | 0.140 |
Why?
|
Glucose Tolerance Test | 4 | 2021 | 1150 | 0.140 |
Why?
|
Puerperal Disorders | 1 | 2019 | 275 | 0.140 |
Why?
|
Social Support | 2 | 2016 | 2117 | 0.140 |
Why?
|
Societies, Medical | 2 | 2019 | 3741 | 0.140 |
Why?
|
Abortion, Habitual | 2 | 1994 | 70 | 0.140 |
Why?
|
Liability, Legal | 1 | 2017 | 213 | 0.140 |
Why?
|
Education | 1 | 2019 | 543 | 0.130 |
Why?
|
Fertilization in Vitro | 1 | 2003 | 1284 | 0.130 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 1 | 1995 | 35 | 0.130 |
Why?
|
Trial of Labor | 2 | 2007 | 80 | 0.130 |
Why?
|
Case-Control Studies | 18 | 2018 | 21752 | 0.130 |
Why?
|
Africa, Western | 1 | 2015 | 154 | 0.130 |
Why?
|
Middle Aged | 20 | 2021 | 213367 | 0.130 |
Why?
|
Young Adult | 17 | 2017 | 56436 | 0.130 |
Why?
|
Blood Transfusion | 2 | 2011 | 1296 | 0.130 |
Why?
|
Respiratory Therapy | 1 | 2015 | 132 | 0.130 |
Why?
|
Acute Kidney Injury | 2 | 2018 | 1971 | 0.130 |
Why?
|
Blood Pressure | 7 | 2018 | 8551 | 0.120 |
Why?
|
Affect | 1 | 2002 | 1475 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 547 | 0.120 |
Why?
|
Airway Resistance | 1 | 2015 | 404 | 0.120 |
Why?
|
Employment | 1 | 2021 | 1129 | 0.120 |
Why?
|
Hysterectomy | 3 | 2015 | 927 | 0.120 |
Why?
|
Genital Diseases, Female | 1 | 2015 | 197 | 0.120 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2019 | 1812 | 0.120 |
Why?
|
Hostility | 1 | 2015 | 189 | 0.120 |
Why?
|
Thyroid Diseases | 1 | 1997 | 378 | 0.120 |
Why?
|
Infant, Small for Gestational Age | 3 | 2018 | 440 | 0.120 |
Why?
|
Tissue Donors | 1 | 2003 | 2242 | 0.120 |
Why?
|
Methylergonovine | 1 | 2013 | 6 | 0.120 |
Why?
|
Exploratory Behavior | 1 | 2015 | 270 | 0.120 |
Why?
|
Maternal Mortality | 1 | 2016 | 310 | 0.120 |
Why?
|
Kidney Calculi | 1 | 2018 | 465 | 0.110 |
Why?
|
Nurse Midwives | 2 | 2003 | 24 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 3 | 2005 | 552 | 0.110 |
Why?
|
Coitus | 1 | 2014 | 133 | 0.110 |
Why?
|
Ethics, Nursing | 1 | 2013 | 25 | 0.110 |
Why?
|
Oxytocics | 1 | 2013 | 68 | 0.110 |
Why?
|
Practice Guidelines as Topic | 4 | 2015 | 7281 | 0.110 |
Why?
|
Texas | 1 | 2014 | 392 | 0.110 |
Why?
|
Lymphangioma, Cystic | 1 | 2012 | 34 | 0.110 |
Why?
|
Fetal Weight | 1 | 2012 | 80 | 0.110 |
Why?
|
Data Collection | 3 | 2013 | 3340 | 0.110 |
Why?
|
Vagina | 2 | 1997 | 825 | 0.110 |
Why?
|
Nuchal Translucency Measurement | 1 | 2012 | 56 | 0.110 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2015 | 317 | 0.100 |
Why?
|
Reminder Systems | 1 | 2015 | 371 | 0.100 |
Why?
|
Advance Directives | 1 | 2014 | 246 | 0.100 |
Why?
|
Hydrops Fetalis | 1 | 2012 | 107 | 0.100 |
Why?
|
Family Practice | 1 | 2015 | 516 | 0.100 |
Why?
|
Cohort Studies | 19 | 2021 | 40559 | 0.100 |
Why?
|
Peer Group | 1 | 2016 | 635 | 0.100 |
Why?
|
Pandemics | 2 | 2022 | 8387 | 0.100 |
Why?
|
Qualitative Research | 2 | 2017 | 2682 | 0.100 |
Why?
|
Abnormalities, Multiple | 3 | 2013 | 1416 | 0.100 |
Why?
|
Bradycardia | 1 | 2012 | 305 | 0.100 |
Why?
|
Uterus | 3 | 2011 | 710 | 0.100 |
Why?
|
Morals | 1 | 2014 | 284 | 0.100 |
Why?
|
Labor Stage, First | 1 | 2010 | 20 | 0.100 |
Why?
|
Truth Disclosure | 1 | 1995 | 436 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2007 | 9960 | 0.100 |
Why?
|
Uterine Hemorrhage | 1 | 1992 | 255 | 0.090 |
Why?
|
Labor Stage, Second | 1 | 2010 | 31 | 0.090 |
Why?
|
Directive Counseling | 1 | 2012 | 166 | 0.090 |
Why?
|
Adolescent | 13 | 2017 | 85759 | 0.090 |
Why?
|
Body Mass Index | 9 | 2018 | 12718 | 0.090 |
Why?
|
Femoral Neoplasms | 1 | 2010 | 77 | 0.090 |
Why?
|
Thoracic Vertebrae | 1 | 2014 | 608 | 0.090 |
Why?
|
Cross-Sectional Studies | 4 | 2021 | 25043 | 0.090 |
Why?
|
Follistatin-Related Proteins | 1 | 2009 | 48 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2020 | 1796 | 0.090 |
Why?
|
Vitamin D-Binding Protein | 1 | 2010 | 129 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 2 | 2015 | 3023 | 0.090 |
Why?
|
State Government | 1 | 2012 | 372 | 0.090 |
Why?
|
Biometry | 1 | 2012 | 558 | 0.090 |
Why?
|
Odds Ratio | 7 | 2015 | 9849 | 0.080 |
Why?
|
Spinal Muscular Atrophies of Childhood | 1 | 2010 | 108 | 0.080 |
Why?
|
Logistic Models | 8 | 2017 | 13409 | 0.080 |
Why?
|
Urinary Tract Infections | 1 | 2014 | 788 | 0.080 |
Why?
|
Health Care Surveys | 2 | 2013 | 2453 | 0.080 |
Why?
|
Toll-Like Receptors | 1 | 2012 | 592 | 0.080 |
Why?
|
Multivariate Analysis | 7 | 2017 | 12244 | 0.080 |
Why?
|
Perception | 1 | 2015 | 1198 | 0.080 |
Why?
|
Body Temperature | 1 | 2011 | 777 | 0.080 |
Why?
|
Professional Autonomy | 1 | 2009 | 177 | 0.080 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2010 | 254 | 0.080 |
Why?
|
Government Regulation | 1 | 2012 | 522 | 0.080 |
Why?
|
Patient Care Planning | 1 | 2013 | 921 | 0.080 |
Why?
|
Twins | 1 | 2009 | 339 | 0.080 |
Why?
|
Nuclear Transfer Techniques | 1 | 2007 | 64 | 0.080 |
Why?
|
Boston | 3 | 2018 | 9311 | 0.070 |
Why?
|
California | 2 | 2009 | 1402 | 0.070 |
Why?
|
Coercion | 1 | 2007 | 63 | 0.070 |
Why?
|
Age Factors | 5 | 2021 | 18367 | 0.070 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1831 | 0.070 |
Why?
|
Propensity Score | 4 | 2015 | 1781 | 0.070 |
Why?
|
Sleep Deprivation | 1 | 2014 | 832 | 0.070 |
Why?
|
Blood Vessels | 1 | 2013 | 1126 | 0.070 |
Why?
|
Choice Behavior | 1 | 2013 | 803 | 0.070 |
Why?
|
Spinal Cord Injuries | 1 | 2014 | 931 | 0.070 |
Why?
|
Probability | 3 | 2007 | 2505 | 0.070 |
Why?
|
Retrospective Studies | 19 | 2023 | 77426 | 0.070 |
Why?
|
Maternal-Fetal Relations | 1 | 2006 | 25 | 0.070 |
Why?
|
Drug Utilization | 1 | 2012 | 1183 | 0.070 |
Why?
|
Research Personnel | 1 | 2011 | 573 | 0.070 |
Why?
|
Perinatology | 1 | 2006 | 57 | 0.070 |
Why?
|
Incidence | 8 | 2018 | 20945 | 0.070 |
Why?
|
Disability Evaluation | 1 | 2013 | 1828 | 0.070 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 1518 | 0.070 |
Why?
|
Disease Outbreaks | 1 | 2015 | 1772 | 0.070 |
Why?
|
Sensitivity and Specificity | 6 | 2013 | 14726 | 0.070 |
Why?
|
Mental Disorders | 2 | 2015 | 6601 | 0.060 |
Why?
|
Massachusetts | 6 | 2018 | 8663 | 0.060 |
Why?
|
Safety Management | 1 | 2011 | 782 | 0.060 |
Why?
|
Osteosarcoma | 1 | 2010 | 881 | 0.060 |
Why?
|
Genetic Counseling | 1 | 2008 | 600 | 0.060 |
Why?
|
Cesarean Section, Repeat | 1 | 2004 | 29 | 0.060 |
Why?
|
Chromium | 1 | 2004 | 123 | 0.060 |
Why?
|
Prospective Studies | 13 | 2010 | 53280 | 0.060 |
Why?
|
General Surgery | 1 | 1995 | 1636 | 0.060 |
Why?
|
Medical Informatics | 1 | 2011 | 743 | 0.060 |
Why?
|
Confidentiality | 1 | 2008 | 612 | 0.060 |
Why?
|
Labor Onset | 1 | 2003 | 16 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3311 | 0.060 |
Why?
|
Referral and Consultation | 2 | 2015 | 3528 | 0.060 |
Why?
|
Receptors, Progesterone | 1 | 2008 | 1097 | 0.060 |
Why?
|
Unnecessary Procedures | 1 | 2007 | 431 | 0.060 |
Why?
|
Parenting | 1 | 2009 | 679 | 0.060 |
Why?
|
Chronic Disease | 3 | 2014 | 9147 | 0.060 |
Why?
|
Health Surveys | 1 | 2013 | 4037 | 0.050 |
Why?
|
Continuity of Patient Care | 1 | 2010 | 1049 | 0.050 |
Why?
|
Seizures | 1 | 2015 | 2859 | 0.050 |
Why?
|
Substance-Related Disorders | 1 | 2019 | 4259 | 0.050 |
Why?
|
Medicaid | 2 | 2013 | 2736 | 0.050 |
Why?
|
Myometrium | 2 | 2008 | 181 | 0.050 |
Why?
|
Lupus Nephritis | 1 | 2005 | 310 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2015 | 19907 | 0.050 |
Why?
|
Peripartum Period | 1 | 2023 | 133 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2010 | 7879 | 0.050 |
Why?
|
Early Diagnosis | 1 | 2007 | 1184 | 0.050 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2012 | 1356 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7659 | 0.050 |
Why?
|
Patient Readmission | 1 | 2015 | 3114 | 0.050 |
Why?
|
Streptococcus agalactiae | 1 | 2003 | 375 | 0.050 |
Why?
|
Feeding Behavior | 1 | 2014 | 3188 | 0.050 |
Why?
|
Embryonic and Fetal Development | 1 | 2002 | 438 | 0.050 |
Why?
|
Case Management | 1 | 2003 | 286 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 3674 | 0.050 |
Why?
|
Dendritic Cells | 1 | 2012 | 2725 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2019 | 5319 | 0.050 |
Why?
|
Infant | 3 | 2023 | 35129 | 0.050 |
Why?
|
Electronic Health Records | 2 | 2015 | 4463 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2014 | 15070 | 0.050 |
Why?
|
Harm Reduction | 1 | 2021 | 129 | 0.050 |
Why?
|
Transplantation, Autologous | 1 | 2005 | 2124 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3256 | 0.040 |
Why?
|
Acute Coronary Syndrome | 1 | 2013 | 2337 | 0.040 |
Why?
|
Evaluation Studies as Topic | 2 | 1999 | 1676 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2015 | 11732 | 0.040 |
Why?
|
Decision Support Techniques | 1 | 2010 | 1955 | 0.040 |
Why?
|
Child | 6 | 2023 | 77679 | 0.040 |
Why?
|
Sleep | 1 | 2015 | 4623 | 0.040 |
Why?
|
Blood Loss, Surgical | 2 | 2015 | 661 | 0.040 |
Why?
|
Plasma Exchange | 1 | 2020 | 155 | 0.040 |
Why?
|
Single-Blind Method | 2 | 2019 | 1590 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2018 | 39045 | 0.040 |
Why?
|
Inflammation | 3 | 2004 | 10634 | 0.040 |
Why?
|
Fasting | 3 | 2016 | 1591 | 0.040 |
Why?
|
Cross-Over Studies | 2 | 2015 | 2032 | 0.040 |
Why?
|
Hospitals | 1 | 2013 | 3952 | 0.040 |
Why?
|
HIV Infections | 2 | 1996 | 16718 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3611 | 0.040 |
Why?
|
Gases | 1 | 1999 | 197 | 0.040 |
Why?
|
Salaries and Fringe Benefits | 1 | 2021 | 264 | 0.040 |
Why?
|
Estradiol | 2 | 2003 | 2020 | 0.040 |
Why?
|
Streptococcal Infections | 1 | 2003 | 638 | 0.040 |
Why?
|
Menopause | 1 | 2007 | 1626 | 0.040 |
Why?
|
RNA-Binding Proteins | 1 | 2008 | 1903 | 0.040 |
Why?
|
Supine Position | 1 | 2019 | 204 | 0.040 |
Why?
|
Thyroid Crisis | 1 | 1997 | 8 | 0.040 |
Why?
|
Karyotyping | 1 | 2000 | 1243 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2003 | 638 | 0.040 |
Why?
|
Infant, Premature | 2 | 2004 | 2044 | 0.040 |
Why?
|
Maternal-Fetal Exchange | 1 | 1999 | 455 | 0.040 |
Why?
|
Organ Transplantation | 1 | 2007 | 1139 | 0.040 |
Why?
|
False Negative Reactions | 1 | 1998 | 587 | 0.040 |
Why?
|
Life Style | 1 | 2008 | 3835 | 0.040 |
Why?
|
Amnion | 1 | 1998 | 209 | 0.040 |
Why?
|
Vitamin D | 1 | 2010 | 3222 | 0.040 |
Why?
|
Neovascularization, Physiologic | 1 | 2004 | 1351 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2005 | 1620 | 0.030 |
Why?
|
Patient Positioning | 1 | 2019 | 323 | 0.030 |
Why?
|
Ovulation Induction | 1 | 1998 | 274 | 0.030 |
Why?
|
Public Health | 1 | 2009 | 2603 | 0.030 |
Why?
|
Proteinuria | 2 | 2013 | 657 | 0.030 |
Why?
|
Child, Preschool | 2 | 2016 | 40992 | 0.030 |
Why?
|
Canada | 1 | 2021 | 2065 | 0.030 |
Why?
|
Testosterone | 2 | 2003 | 2411 | 0.030 |
Why?
|
Tilt-Table Test | 1 | 2015 | 78 | 0.030 |
Why?
|
Age Distribution | 1 | 2001 | 2903 | 0.030 |
Why?
|
Chorioamnionitis | 1 | 1996 | 155 | 0.030 |
Why?
|
Rupture | 1 | 1997 | 433 | 0.030 |
Why?
|
Hyperthyroidism | 1 | 1997 | 295 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2005 | 2038 | 0.030 |
Why?
|
Philosophy, Medical | 1 | 1995 | 79 | 0.030 |
Why?
|
Infant, Premature, Diseases | 1 | 2001 | 706 | 0.030 |
Why?
|
Databases, Factual | 3 | 2017 | 7730 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2014 | 2970 | 0.030 |
Why?
|
Clinical Competence | 1 | 2010 | 4687 | 0.030 |
Why?
|
Digestive System Diseases | 1 | 2015 | 147 | 0.030 |
Why?
|
Male | 10 | 2021 | 350027 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2004 | 2636 | 0.030 |
Why?
|
Methyldopa | 1 | 2013 | 20 | 0.030 |
Why?
|
Nitric Oxide Synthase | 1 | 1997 | 916 | 0.030 |
Why?
|
Labetalol | 1 | 2013 | 30 | 0.030 |
Why?
|
Zidovudine | 1 | 1996 | 620 | 0.030 |
Why?
|
Uterine Inertia | 1 | 2013 | 29 | 0.030 |
Why?
|
Iodine Radioisotopes | 1 | 1997 | 1032 | 0.030 |
Why?
|
Thyroxine | 1 | 1997 | 666 | 0.030 |
Why?
|
Prognosis | 4 | 2013 | 29050 | 0.030 |
Why?
|
Registries | 2 | 2016 | 8090 | 0.030 |
Why?
|
Sweden | 1 | 2016 | 1345 | 0.030 |
Why?
|
Laparotomy | 1 | 2015 | 473 | 0.030 |
Why?
|
Obesity | 2 | 2009 | 12742 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2000 | 1404 | 0.030 |
Why?
|
Compliance | 1 | 2013 | 104 | 0.030 |
Why?
|
Uterine Perforation | 1 | 1992 | 6 | 0.030 |
Why?
|
Wound Healing | 1 | 2004 | 2785 | 0.030 |
Why?
|
Guideline Adherence | 1 | 2003 | 2266 | 0.030 |
Why?
|
Solubility | 2 | 2004 | 1083 | 0.030 |
Why?
|
Fetal Heart | 1 | 1994 | 276 | 0.030 |
Why?
|
Hypothyroidism | 1 | 1997 | 659 | 0.030 |
Why?
|
Uric Acid | 1 | 1998 | 765 | 0.030 |
Why?
|
Siblings | 1 | 2016 | 854 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2013 | 11728 | 0.030 |
Why?
|
Disease Progression | 1 | 2008 | 13280 | 0.030 |
Why?
|
Blood Component Transfusion | 1 | 1992 | 142 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2017 | 853 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2018 | 780 | 0.020 |
Why?
|
Diagnosis-Related Groups | 1 | 2013 | 455 | 0.020 |
Why?
|
Manometry | 1 | 2013 | 445 | 0.020 |
Why?
|
Thyroid Gland | 1 | 1997 | 1172 | 0.020 |
Why?
|
Hemostatic Techniques | 1 | 2011 | 116 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2018 | 2170 | 0.020 |
Why?
|
Electromyography | 1 | 2015 | 1391 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 2010 | 5396 | 0.020 |
Why?
|
Obstetrics and Gynecology Department, Hospital | 1 | 2010 | 43 | 0.020 |
Why?
|
Patient Admission | 1 | 2018 | 1380 | 0.020 |
Why?
|
Hirschsprung Disease | 1 | 1992 | 155 | 0.020 |
Why?
|
Regression Analysis | 2 | 1997 | 6461 | 0.020 |
Why?
|
HIV Seropositivity | 1 | 1996 | 971 | 0.020 |
Why?
|
Proteins | 1 | 2005 | 6101 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2013 | 937 | 0.020 |
Why?
|
Survival of Motor Neuron 1 Protein | 1 | 2010 | 64 | 0.020 |
Why?
|
Chromosome Disorders | 1 | 1993 | 515 | 0.020 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2009 | 45 | 0.020 |
Why?
|
Blastocyst | 1 | 1993 | 424 | 0.020 |
Why?
|
Biological Assay | 1 | 1993 | 652 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2007 | 15538 | 0.020 |
Why?
|
Polysomnography | 1 | 2015 | 1775 | 0.020 |
Why?
|
Progesterone | 1 | 1993 | 776 | 0.020 |
Why?
|
Microcirculation | 1 | 2013 | 1286 | 0.020 |
Why?
|
Drug Costs | 1 | 1996 | 1105 | 0.020 |
Why?
|
Immunomodulation | 1 | 2012 | 541 | 0.020 |
Why?
|
Religion | 1 | 2011 | 356 | 0.020 |
Why?
|
Proportional Hazards Models | 3 | 2012 | 12355 | 0.020 |
Why?
|
Arteries | 1 | 2013 | 1119 | 0.020 |
Why?
|
Limb Salvage | 1 | 2010 | 433 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2012 | 19227 | 0.020 |
Why?
|
Primary Health Care | 2 | 2015 | 4556 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2013 | 1504 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 1993 | 1814 | 0.020 |
Why?
|
Clinical Chemistry Tests | 1 | 2005 | 61 | 0.020 |
Why?
|
Endometrium | 1 | 2008 | 424 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2015 | 2759 | 0.020 |
Why?
|
Survival Analysis | 2 | 2013 | 10250 | 0.020 |
Why?
|
Outpatients | 1 | 2012 | 1486 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2277 | 0.020 |
Why?
|
Artifacts | 1 | 2013 | 1903 | 0.010 |
Why?
|
Physician-Nurse Relations | 1 | 2003 | 20 | 0.010 |
Why?
|
Laparoscopy | 1 | 2015 | 2149 | 0.010 |
Why?
|
Quality-Adjusted Life Years | 1 | 2010 | 1683 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2012 | 1889 | 0.010 |
Why?
|
Growth Substances | 1 | 2005 | 783 | 0.010 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2015 | 2408 | 0.010 |
Why?
|
Steroids | 1 | 2008 | 931 | 0.010 |
Why?
|
Hemodynamics | 1 | 2013 | 4199 | 0.010 |
Why?
|
Length of Stay | 1 | 2015 | 6308 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2008 | 1971 | 0.010 |
Why?
|
Nephrotic Syndrome | 1 | 2005 | 389 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2012 | 12075 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6367 | 0.010 |
Why?
|
Nurse's Role | 1 | 2003 | 209 | 0.010 |
Why?
|
Models, Statistical | 1 | 1996 | 5102 | 0.010 |
Why?
|
Perinatal Care | 1 | 2003 | 227 | 0.010 |
Why?
|
Pilot Projects | 1 | 2014 | 8321 | 0.010 |
Why?
|
Electroencephalography | 1 | 2015 | 6150 | 0.010 |
Why?
|
Blotting, Western | 1 | 2008 | 5180 | 0.010 |
Why?
|
Pulsatile Flow | 1 | 2001 | 332 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 1993 | 4151 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 2005 | 804 | 0.010 |
Why?
|
Models, Organizational | 1 | 2003 | 574 | 0.010 |
Why?
|
Infant, Low Birth Weight | 1 | 2004 | 850 | 0.010 |
Why?
|
Radiography | 1 | 2010 | 7022 | 0.010 |
Why?
|
Patient Care Team | 1 | 2010 | 2529 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2004 | 15161 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2004 | 2886 | 0.010 |
Why?
|
Survival Rate | 1 | 2013 | 12781 | 0.010 |
Why?
|
Ultrasonography | 1 | 2011 | 5982 | 0.010 |
Why?
|
Infant Mortality | 1 | 2003 | 754 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2014 | 4586 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2005 | 12961 | 0.010 |
Why?
|
Cytokines | 1 | 2012 | 7326 | 0.010 |
Why?
|
Health Resources | 1 | 2003 | 911 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1997 | 475 | 0.010 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2001 | 341 | 0.010 |
Why?
|
Pain | 1 | 2011 | 4987 | 0.010 |
Why?
|
Retinopathy of Prematurity | 1 | 2001 | 421 | 0.010 |
Why?
|
Health Services Research | 1 | 2003 | 1836 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 3923 | 0.010 |
Why?
|
Morbidity | 1 | 2001 | 1769 | 0.010 |
Why?
|
Social Class | 1 | 2004 | 1999 | 0.010 |
Why?
|
Time Factors | 2 | 2009 | 40063 | 0.010 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2003 | 941 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2012 | 11478 | 0.010 |
Why?
|
Wounds, Penetrating | 1 | 1996 | 307 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2004 | 3506 | 0.010 |
Why?
|
Mice | 2 | 2008 | 81178 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2005 | 2103 | 0.010 |
Why?
|
Brain | 1 | 2000 | 26413 | 0.010 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 1996 | 434 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 13036 | 0.010 |
Why?
|
Birth Order | 1 | 1992 | 95 | 0.010 |
Why?
|
Aged | 2 | 2021 | 163253 | 0.010 |
Why?
|
ROC Curve | 1 | 1998 | 3527 | 0.010 |
Why?
|
Medical History Taking | 1 | 1994 | 783 | 0.010 |
Why?
|
Kidney | 1 | 2005 | 7183 | 0.010 |
Why?
|
Animals | 2 | 2008 | 168788 | 0.010 |
Why?
|
Comorbidity | 1 | 2002 | 10387 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2011 | 63119 | 0.000 |
Why?
|
Gene Expression | 1 | 1997 | 7799 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1997 | 11368 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 35423 | 0.000 |
Why?
|
Family | 1 | 1992 | 3148 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 1997 | 57768 | 0.000 |
Why?
|